Table of Contents

Executive Summary

1 Industry Overview of Macrolide Drugs

• 1.1 Definition of Macrolide Drugs
• 1.2 Macrolide Drugs Segment by Type
  • 1.2.1 Global Macrolide Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 14-Membered Ring Agents
  • 1.2.3 15-Membered Ring Agents
  • 1.2.4 16-Membered Ring Agents
  • 1.2.5 Ketolides
• 1.3 Macrolide Drugs Segment by Applications
  • 1.3.1 Global Macrolide Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Hospitalshospital Pharmacies
  • 1.3.5 Retail Pharmacies
  • 1.3.6 Online Pharmacies
• 1.4 Global Macrolide Drugs Overall Market
  • 1.4.1 Global Macrolide Drugs Revenue (2014-2025)
  • 1.4.2 Global Macrolide Drugs Production (2014-2025)
  • 1.4.3 North America Macrolide Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Macrolide Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Macrolide Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Macrolide Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Macrolide Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Macrolide Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Macrolide Drugs
• 2.3 Manufacturing Process Analysis of Macrolide Drugs
• 2.4 Industry Chain Structure of Macrolide Drugs

3 Development and Manufacturing Plants Analysis of Macrolide Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Macrolide Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Macrolide Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Macrolide Drugs Production and Capacity Analysis
• 4.2 Macrolide Drugs Revenue Analysis
• 4.3 Macrolide Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Macrolide Drugs Regional Market Analysis

• 5.1 Macrolide Drugs Production by Regions
  • 5.1.1 Global Macrolide Drugs Production by Regions
  • 5.1.2 Global Macrolide Drugs Revenue by Regions
• 5.2 Macrolide Drugs Consumption by Regions
• 5.3 North America Macrolide Drugs Market Analysis
  • 5.3.1 North America Macrolide Drugs Production
  • 5.3.2 North America Macrolide Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Macrolide Drugs Import and Export
• 5.4 Europe Macrolide Drugs Market Analysis
  • 5.4.1 Europe Macrolide Drugs Production
  • 5.4.2 Europe Macrolide Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Macrolide Drugs Import and Export
• 5.5 China Macrolide Drugs Market Analysis
  • 5.5.1 China Macrolide Drugs Production
  • 5.5.2 China Macrolide Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Macrolide Drugs Import and Export
• 5.6 Japan Macrolide Drugs Market Analysis
  • 5.6.1 Japan Macrolide Drugs Production
  • 5.6.2 Japan Macrolide Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Macrolide Drugs Import and Export
• 5.7 Southeast Asia Macrolide Drugs Market Analysis
  • 5.7.1 Southeast Asia Macrolide Drugs Production
  • 5.7.2 Southeast Asia Macrolide Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Macrolide Drugs Import and Export
• 5.8 India Macrolide Drugs Market Analysis
  • 5.8.1 India Macrolide Drugs Production
  • 5.8.2 India Macrolide Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Macrolide Drugs Import and Export

6 Macrolide Drugs Segment Market Analysis (by Type)

• 6.1 Global Macrolide Drugs Production by Type
• 6.2 Global Macrolide Drugs Revenue by Type
• 6.3 Macrolide Drugs Price by Type

7 Macrolide Drugs Segment Market Analysis (by Application)

• 7.1 Global Macrolide Drugs Consumption by Application
• 7.2 Global Macrolide Drugs Consumption Market Share by Application (2014-2019)

8 Macrolide Drugs Major Manufacturers Analysis

• 8.1 Abbott Laboratories
  • 8.1.1 Abbott Laboratories Macrolide Drugs Production Sites and Area Served
  • 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
  • 8.1.3 Abbott Laboratories Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Akorn
  • 8.2.1 Akorn Macrolide Drugs Production Sites and Area Served
  • 8.2.2 Akorn Product Introduction, Application and Specification
  • 8.2.3 Akorn Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Eli Lilly & Co.
  • 8.3.1 Eli Lilly & Co. Macrolide Drugs Production Sites and Area Served
  • 8.3.2 Eli Lilly & Co. Product Introduction, Application and Specification
  • 8.3.3 Eli Lilly & Co. Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Fresenius Kabi
  • 8.4.1 Fresenius Kabi Macrolide Drugs Production Sites and Area Served
  • 8.4.2 Fresenius Kabi Product Introduction, Application and Specification
  • 8.4.3 Fresenius Kabi Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Gland Pharmm
  • 8.5.1 Gland Pharmm Macrolide Drugs Production Sites and Area Served
  • 8.5.2 Gland Pharmm Product Introduction, Application and Specification
  • 8.5.3 Gland Pharmm Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sirolimus
  • 8.6.1 Sirolimus Macrolide Drugs Production Sites and Area Served
  • 8.6.2 Sirolimus Product Introduction, Application and Specification
  • 8.6.3 Sirolimus Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Neo Química
  • 8.7.1 Neo Química Macrolide Drugs Production Sites and Area Served
  • 8.7.2 Neo Química Product Introduction, Application and Specification
  • 8.7.3 Neo Química Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Tacorolimus
  • 8.8.1 Tacorolimus Macrolide Drugs Production Sites and Area Served
  • 8.8.2 Tacorolimus Product Introduction, Application and Specification
  • 8.8.3 Tacorolimus Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Macrolide Pharmaceuticals
  • 8.9.1 Macrolide Pharmaceuticals Macrolide Drugs Production Sites and Area Served
  • 8.9.2 Macrolide Pharmaceuticals Product Introduction, Application and Specification
  • 8.9.3 Macrolide Pharmaceuticals Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Mylan
  • 8.10.1 Mylan Macrolide Drugs Production Sites and Area Served
  • 8.10.2 Mylan Product Introduction, Application and Specification
  • 8.10.3 Mylan Macrolide Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Pfizer
• 8.12 Sanofi
• 8.13 Merck & Co.
• 8.14 Sandoz International
• 8.15 Teva Pharmaceutical Industries
• 8.16 WOCKHARDT

9 Development Trend of Analysis of Macrolide Drugs Market

• 9.1 Global Macrolide Drugs Market Trend Analysis
  • 9.1.1 Global Macrolide Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Macrolide Drugs Regional Market Trend
  • 9.2.1 North America Macrolide Drugs Forecast 2019-2025
  • 9.2.2 Europe Macrolide Drugs Forecast 2019-2025
  • 9.2.3 China Macrolide Drugs Forecast 2019-2025
  • 9.2.4 Japan Macrolide Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Macrolide Drugs Forecast 2019-2025
  • 9.2.6 India Macrolide Drugs Forecast 2019-2025
• 9.3 Macrolide Drugs Market Trend (Product Type)
• 9.4 Macrolide Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Macrolide Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The macrolide drugs are a group of antibiotics produced by various strains of Streptomyces (spore forming bacteria that grow slowly in soil or water as a branching filamentous mycelium similar to that of fungi) and have a complex chemical (macrocyclic) structure. They act by inhibiting protein synthesis, specifically by blocking the 50S ribosomal subunit. They are broad spectrum antibiotics.

The global Macrolide Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Macrolide Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Macrolide Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Macrolide Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Macrolide Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
Akorn
Eli Lilly & Co.
Fresenius Kabi
Gland Pharmm
Sirolimus
Neo Química
Tacorolimus
Macrolide Pharmaceuticals
Mylan
Pfizer
Sanofi
Merck & Co.
Sandoz International
Teva Pharmaceutical Industries
WOCKHARDT

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
14-Membered Ring Agents
15-Membered Ring Agents
16-Membered Ring Agents
Ketolides

Segment by Application
Hospitals
Clinics
Hospitalshospital Pharmacies
Retail Pharmacies
Online Pharmacies